Clinical Trials Logo

Vulvar Neoplasms clinical trials

View clinical trials related to Vulvar Neoplasms.

Filter by:

NCT ID: NCT00006096 Terminated - Vulvar Cancer Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva

Start date: March 2001
Phase: Phase 3
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if radiation therapy combined with chemotherapy kills more tumor cells than radiation therapy alone in treating cancer of the vulva. PURPOSE: Randomized phase III trial to determine the effectiveness of radiation therapy with or without cisplatin in treating patients who have stage I, stage II, or stage III cancer of the vulva.

NCT ID: NCT00003525 Terminated - Clinical trials for Vulvar Cancer, Stage IV

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Start date: June 3, 1996
Phase: Phase 2
Study type: Interventional

Current therapies for Stage IV Cancer of the Cervix and/or Vulva provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Cancer of the Cervix and/or Vulva. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Cancer of the Cervix and/or Vulva.